Health-related spam

Sep 18, 2007

A new study in PLoS Medicine has found that a third of all spam messages advertise health products such as drugs and natural health products and that it is easy to purchase prescription drugs and controlled substances advertised in these messages.

Peter Gernburd and Alejandro Jadad at the Centre for Global eHealth Innovation, University of Toronto and University Health Network, Canada, studied e-mail messages sent to three accounts over a one month period. The three accounts received 4,153 spam messages (82% of the total messages received), and a third of this spam was health-related.

The health-related spam mostly came from the US (73%), followed by China (16%) and the Democratic Republic of Congo (5%).

The researchers were able to successfully purchase products purported to be Valium and Xanax (sedatives), Tramadol (an opiate pain killer), Cialis (a drug for erectile dysfunction), and Meridia (an anti-obesity drug), as well as several mixtures of natural health products to promote weight reduction or improvement of male sexual function.

"As the number of people who turn to the Internet looking for health or lifestyle problems increases," say the authors, "merchants will rise to the occasion, matching the demand. As this study has shown, current regulatory, legal, and geographic boundaries are unable to contain the flow of products across the world."

Source: Public Library of Science

Explore further: Analgesics prescribed more heavily to women than to men, study finds

add to favorites email to friend print save as pdf

Related Stories

Google Glass a hit with early adopters

May 09, 2013

Back when she was in college, software developer Monica Wilkinson says, she used to dream of "being able to carry a computer in my head," instead of lugging her books and laptop all over campus. As she tried ...

Waiting for Apple's iWatch

Mar 22, 2013

With Apple's stock hobbling and questions lingering about its ability to innovate in the post-Steve Jobs era, investors and fans are latching on to hopes that the tech giant's next big thing will be the iWatch.

Recommended for you

FDA has safety concerns on Merck insomnia drug

May 20, 2013

Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.

US adviser on board of firm that sold anthrax drug

May 20, 2013

(AP)—Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while ...

First influenza vaccine brought to clinical testing

May 17, 2013

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...

User comments : 0

More news stories

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Internet cable from Cuba to Jamaica comes online

A new branch of the Venezuela-to-Cuba undersea fiber-optic cable has reportedly come online, linking the island to nearby Jamaica, increasing Cuba's potential international communications bandwidth and providing a backup ...